Net Income

Vancouver-based TRUBAR agrees to a C$201M buyout by Turkish food conglomerate ETİ Gıda, marking a major move in the booming plant-based snack market.

The appointment of Mars, Inc. veteran Valerie Mars to PureCycle's board signals a major validation for the advanced plastic recycling firm's technology.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

After a challenging year marked by a mine fire and merger pains, Core Natural Resources is back online, signaling a major financial turnaround for 2026.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

Hainan launches unprecedented island-wide customs operations, aiming to become a global trade hub. But can it balance openness with control and rival giants?

A massive order for a new South American copper mine highlights the critical link between advanced mining technology and the world's green energy needs.

Celltrion's SteQeyma autoinjector gets a CHMP nod, enhancing patient care and intensifying competition in Europe's crowded biosimilar market.

Bolstered by positive clinical data and top investors, Kalaris Therapeutics extends its runway to advance TH103, a next-gen treatment for neovascular AMD.

New Measure A funds will provide emergency rental aid to thousands of at-risk households, marking a major step in the county's new housing strategy.

Semrush's new app brings live marketing data directly into ChatGPT, promising a new era of efficiency and reshaping the competitive SaaS battleground.

The insurer's routine preferred stock dividend declaration masks a deeper story of record profits, strategic execution, and strong analyst confidence.

An international expert panel endorses an advanced wound therapy, potentially revolutionizing patient recovery and boosting a key player in the med-tech market.

Early Phase 1a data for Kalaris's new nAMD drug shows significant vision improvement and potential for extended durability, aiming to reduce patient burden.

A 120-day 'Cape to Cape' voyage introduces complimentary expedition adventures, setting a new standard for ultra-luxury world cruising.

As holiday needs surge, a $75,000 donation from a local credit union provides critical support to organizations battling hunger and homelessness in the region.

Incyte's Minjuvi, a first-of-its-kind immunotherapy, gains EC approval for follicular lymphoma, offering patients a powerful new chemo-free option.

Leading wellness franchise Prime IV Hydration & Wellness lands major financing to accelerate its rapid expansion in the booming IV therapy market.

After 40 years, CEO Michael Magnavita will retire in 2026. Internal successor Drew Stanley is set to lead the award-winning institution's next chapter.